arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Voyager Therapeutics, Inc.

VYGR Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.75
▼ -13.1% Today
as of Oct 23, 15:37 ET
Last 30 days -45.30% Sep 14 → Oct 23
$1.63 $2.05 $2.47 $2.89 $3.31 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.03
High
$2.05
Low
$1.75
Volume
$1M
Avg Vol
$610,863
Mkt Cap
$165M
P/E (TTM)
—
Beta
—
52w High
$5.48
52w Low
$1.75
Div Yield
—
Shares Out
$61M

Recent Press Releases & News last 60 days · 3 items

Oct 21 · 12:01 PR GlobeNewswire
Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
Sep 11 · 12:31 MT Newswires
Palantir, Voyager-Backed Starlab Seeks ISS Microgravity Research Proposals
Sep 1 · 12:00 PR GlobeNewswire
Voyager to Present at Upcoming Investor Conferences

VYGR earnings at a glance

The options market is pricing a move of about ±11.2% after the report, a range of roughly $1.55 to $1.95 from today's $1.75. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±6.0% on average; after the most recent report on May 7, 2026 it moved -5.0%. That means options currently expect more movement than VYGR has typically delivered. VYGR beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 72%. The share price of $1.75 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.75
$5.48
0% of range
Avg surprise (last 4)
-11.5%
Avg reaction (last 2)
-6.0%
0% positive
Latest IV / EM
72%
EM ±11.2% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.59$0.29$1.17$2.06$2.94 Actual $2.94Actual $-0.51Actual $-0.59Actual $-0.20Actual $-0.18Actual $-0.16Actual $-0.53Est $-0.35Actual $-0.57Est $-0.48Actual $-0.47Est $-0.53Actual $-0.47Est $-0.54Actual $-0.40 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-33M$-19M$-4M$11M$26M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.40 — — — — financials
Thu May 7, 2026Mar/2026 $-0.47 $-0.54 +13.0% +11.3% -5.0% earnings
Mon Nov 10, 2025Sep/2025 $-0.47 $-0.53 +11.3% — — earnings
Wed Aug 6, 2025Jun/2025 $-0.57 $-0.48 -18.8% — — earnings
Tue May 6, 2025Mar/2025 $-0.53 $-0.35 -51.4% — -6.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.16 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.18 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.20 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.59 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.51 — — — — financials
Fri Mar 31, 2023Mar 2023 $2.94 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$3M$3M—$13M$5M$6M—$25M
Cost of revenue————————
Gross profit————————
Operating income$-26M$-30M—$-31M$-37M$-35M—$-14M
Net income$-24M$-28M—$-28M$-33M$-31M—$-9M
EPS (diluted)$-0.40$-0.47—$-0.47$-0.57$-0.53—$-0.16

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$36M$43M$65M$45M$44M$75M$71M$113M
Inventory————————
Total current assets$125M$147M$203M$220M$228M$245M$277M$373M
Total assets$198M$219M$252M$288M$322M$353M$393M$426M
Long-term debt————————
Total liabilities$43M$46M$56M$68M$78M$81M$93M$96M
Total equity$154M$174M$196M$220M$244M$273M$300M$330M

Implied volatility — last 90 days

29%977%1924%2872%3820% Jun 12 — IV 1229% · EM ±125.7%Jun 15 — IV 1638% · EM ±118.5%Jun 16 — IV 2062% · EM ±121.8%Jun 17 — IV 860% · EM ±35.9%Jun 19 — IV 578% · EM ±127.7%Jun 22 — IV 111% · EM ±23.2%Jun 23 — IV 350% · EM ±71.6%Jun 24 — IV 75% · EM ±14.9%Jun 25 — IV 362% · EM ±70.8%Jun 26 — IV 58% · EM ±11.1%Jun 29 — IV 71% · EM ±12.6%Jul 02 — IV 82% · EM ±13.2%Jul 03 — IV 85% · EM ±13.2%Jul 06 — IV 100% · EM ±13.8%Jul 07 — IV 60% · EM ±7.9%Jul 08 — IV 64% · EM ±8.0%Jul 16 — IV 3820% · EM ±159.5%Jul 20 — IV 382% · EM ±90.3%Jul 21 — IV 62% · EM ±14.3%Jul 22 — IV 71% · EM ±16.1%Jul 23 — IV 65% · EM ±14.6%Jul 24 — IV 73% · EM ±16.1%Jul 27 — IV 77% · EM ±16.2%Jul 28 — IV 80% · EM ±16.4%Jul 29 — IV 75% · EM ±15.0%Jul 30 — IV 67% · EM ±13.2%Jul 31 — IV 69% · EM ±13.2%Aug 03 — IV 75% · EM ±13.3%Aug 04 — IV 65% · EM ±11.2%Aug 05 — IV 68% · EM ±11.3%Aug 06 — IV 69% · EM ±11.2%Aug 07 — IV 59% · EM ±9.2%Aug 11 — IV 59% · EM ±7.8%Aug 12 — IV 50% · EM ±6.2%Aug 24 — IV 63% · EM ±13.1%Aug 26 — IV 36% · EM ±7.2%Aug 27 — IV 30% · EM ±5.8%Aug 28 — IV 30% · EM ±5.7%Aug 31 — IV 397% · EM ±70.3%Sep 01 — IV 34% · EM ±5.9%Sep 02 — IV 34% · EM ±5.7%Sep 08 — IV 33% · EM ±4.4%Sep 21 — IV 74% · EM ±15.5%Sep 22 — IV 137% · EM ±28.1%Sep 23 — IV 87% · EM ±17.4%Sep 24 — IV 128% · EM ±25.0%Sep 25 — IV 146% · EM ±28.0%Sep 28 — IV 157% · EM ±27.8%Sep 29 — IV 121% · EM ±20.8%Sep 30 — IV 91% · EM ±15.2%Oct 01 — IV 122% · EM ±19.7%Oct 02 — IV 72% · EM ±11.2%

Sector peers

OTLK
Outlook Therapeutics, Inc.
$165M $0.52-7.3%
TARA
Protara Therapeutics, Inc.
$163M $2.35-5.8%
DTIL
Precision BioSciences, Inc.
$173M $6.63-1.2%
CHRS
Coherus Oncology, Inc.
$156M $1.01-1.0%
ABOS
Acumen Pharmaceuticals, Inc.
$150M $1.99-2.0%
CMPX
Compass Therapeutics, Inc.
$184M $0.76-7.1%

VYGR earnings FAQ

What is VYGR's expected move for earnings?

Options currently price a move of about ±11.2%, or $0.20 per share either way from $1.75.

How does VYGR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±6.0%, up 0 times and down 2 times.

What is VYGR's implied volatility?

VYGR's at-the-money implied volatility is about 72% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in